S
inus-lift for implant placement is a very predictable and reproducible surgery. 1, 2 The choice of the technique, either lateral using a Caldwell-Luc osteotomy or axial with the Summers osteotomy, 3 is mainly dependent on the residual bone height of the alveolar ridges, and both techniques show similar results. 2, 4 One key question that remains is to define the best filling material for the subsinus cavity after lifting the sinus membrane. The consensual approach is to consider that most materials are efficient for this surgery, considering the high osteogenic potential of the Schneiderian membrane and its periosteum-like behavior. 5, 6 However, the choice of material or association of materials will influence the waiting period before adequate healing and remodeling of the grafted material, implant placement, and functional loading. Many materials are potentially usable in this clinical situation 7 : autogenous bone graft (parietal, iliac, chin, retromolar, etc), xenograft (bovine, swine, etc), and allograft or synthetic (␤-tricalcium phosphate, hydroxyapatite, etc). Recently, the possibility of sinus-lift without any grafted material is hotly debated, following the concepts of guided bone regeneration. Indeed, in a closed cavity such as a lifted sinus, the osteogenic potential of the bone and the sinus membrane is highly protected and efficient. This concept of limited grafting was first developed with the Summers osteotomy, using no grafting material even in thin residual bone height. 4, 8 And, recently, authors have shown that a full sinus-lift can be performed using the lateral approach with whole blood as sole filling material. 9, 10 The key point of this new guided bone regeneration strategy is to maintain the Schneiderian membrane in the highest possible position, using simultaneous implantation 11 : implants are stabilized in the residual bone height, and their tips keep membrane to the adequate height such as "tent pegs." The main problem of this approach is that filling the subsinus cavity with a stabilized blood clot is not that easy in everyday practice. Moreover, this technique implies that there should be a perfect membrane lifting without membrane tears.
Choukroun's platelet-rich fibrin (PRF) is actually the more simple and inexpensive technique available in the field of platelet concentrate technologies. 12 It was first described by Choukroun et al 13 in 2001 in France and was classified as a leukocyte-and plateletrich fibrin (L-PRF) concentrate. 12 In this simple technique, blood is collected without anticoagulant and immediately centrifuged with low forces. Three layers appear in the tube then: a red blood cell base at the bottom, an acellular plasma as supernatant (platelet-poor plasma), and a PRF clot in the middle. 14 This product is very different from the common previously described platelet-rich plasma (PRP): Choukroun's PRF is a consistent fibrin biomaterial and not a platelet-enriched fibrin glue such as the various plateletrich plasmas. 15 Moreover, the protocol being very inexpensive and easy, many PRF clots can be produced simultaneously: a very significant volume of biomaterial can be produced in less than 20 minutes. The clots can then be transformed into fibrin membranes by compression between sterile gauzes or by using the PRF Box (Process, Nice, France), a surgical box especially designed to collect and standardize PRF clots and membranes. 16 Each PRF membrane concentrates most platelets and more than the half of the leukocytes from a 9-mL blood harvest, merged or enmeshed into a dense fibrin network. [17] [18] [19] This fibrin biomaterial releases high amounts of growth factors (such as transforming growth factor ␤1, platelet-derived growth factor AB, and vascular endothelial growth factor) and matrix glycoproteins (such as thrombospondin-1) during at least 7 days in vitro. 20 Some PRF applications were already described in oral and maxillofacial surgery, 21, 22 ENT and plastic surgery, 23, 24 and preimplant and implant surgery. [25] [26] [27] [28] [29] [30] In a first publication on this subject, 26 it was assessed that a sinus grafting material built with allograft and PRF in equal volume was suitable for implantation after only 4 months and potentially even more mature than a sole allograft after 8 months. Another study 28 showed that PRF membranes were easy to use during Summers osteotomy and offered a good compromise as filling material, shock absorber during sinus floor elevation, and healing support for the damaged Schneiderian membrane.
The objectives of this work were to describe the use of PRF clots and membranes as sole filling material during lateral sinus-lift with immediate implantation, the evolution of the technical procedure during a 6-year period, and the clinical success rate of this procedure in a significant case series.
DESCRIPTION OF THE TECHNICAL PROCEDURE

PRF Preparation
PRF clots and membranes were prepared as described by Choukroun et al. During surgery, 72 mL whole blood was drawn in 8 glass-coated plastic tubes, 31 without anticoagulant, and was immediately centrifuged at about 400g during 12 minutes, using a table centrifuge specifically designed for this application (PC02; Process). Platelets were immediately activated, thus triggering a coagulation cascade. The result was a fibrin clot located in the middle of each tube. Each clot was removed from the tube and separated from the red blood cell base with pliers, then stored in metal cups before subsinus filling. Some clots were gently pressed in between 2 sterile compresses to obtain an autologous fibrin membrane. Five clots and 3 membranes were generally produced in this way for the treatment of each sinus. In Fig. 1 . This patient was 1 of the first of this series. CT-scan was performed before surgery and showed a SA4 sinus anatomy (A, B), with a thin residual bone height (often less than 2 mm). During surgery, 2 significant perforations were done in the Schneiderian membrane while detaching the window bone plate from the membrane (C). The sinus membrane was then carefully lifted and covered with 2 PRF membranes to close the perforations. AstraTech implants were inserted, and their tip blocked the PRF-patched sinus membrane in high position (D). The subsinus cavity was then filled with PRF clots, and the bone window was finally closed with a PRF membrane only, the bone window fragment being too big and, thus, difficult to block correctly to close the subsinus regeneration cavity (E).
the last cases, the PRF box was systematically used for the collection and preparation of standardized clots and membranes. The initial technique was a classical lateral sinus-lift using the Caldwell-Luc approach. Surgery was performed with local anesthesia. Access to the buccal maxillary wall was achieved via a mucosal crestal incision and anterior and posterior releasing vestibular incisions. A large bone window was outlined using a diamond bur on a surgical handpiece, with constant saline irrigation. After careful elevation of the Schneiderian membrane, the bone window was still attached to the membrane and served as a new sinus floor. In one of the first cases, the bone plate was carefully separated from the lifted sinus membrane ( Fig. 1 ) to close the subsinus cavity after filling; however, the bone fragment was finally unusable, because it was too large and difficult to stabilize correctly (it would have lead to a bone sequestrum).
Two PRF membranes were placed on the Schneiderian membrane to protect it before implant drilling and to heal all visible or invisible holes and tears of the sinus membrane. Implant sites were then prepared with a careful drilling. To avoid sinus membrane perforation and to compress the residual bone height, the final stage of osteotomy was performed with a manual osteotome. Implants were then inserted in compression within the residual alveolar bone. Implant stability was always obtained because of the tapered profiles and the microthreaded collars of the implants. The end of the implants always touched the PRF membranes covering the released sinus membrane and served as tent pegs (Fig. 1, D) .
Five PRF clots on average were then inserted and compressed inside the subsinus cavity to fill all the volume stabilized with the implants. Finally, 1 PRF membrane was used to cover the osteotomy window and protect the filled subsinus from potential mucogingival invagination ( Fig. 1, E) .
For postoperative management, medications were prescribed, including chlorhexidine rinses twice a day until sutures removal, 1 g amoxicillin (2 times daily for 6 days; pristinamycin 2 ϫ 100 mg, 2 times daily was prescribed in penicillin-sensitive patients), ibuprofen (400 mg) 4 times daily unless medically contraindicated, and pain medication as needed for pain. Patients were not allowed to use any removable prosthesis. The sutures were removed 8 to 10 days postoperatively.
Evolution of the Technique
The first main evolution appeared since 2005 and was related to the position and size of the Caldwell-Luc bony window. In the first cases, the window was outlined quite close from the crestal horizontal part (ϳ4 mm above the crestal line), and the sinus was widely opened, using a quite large bone incision (Fig. 1, C and D) . This technique allowed a better viewpoint and control of the PRF membranes and implant placement but presented some disadvantages. Indeed, tapered implants were inserted in compression with a quite high torque and blocked in the residual bone height (thin in SA4 sinus), and crestal fractures may occur. This event could have severe consequences, because this technique required the implants to be stable and to maintain the sinus membrane in Fig. 2 . Twenty days after surgery, a first panoramic x-ray showed the Astra implants blocked in the thin residual bone height (1 mm), with ϳ12 mm of the implant standing in the sinus without bone: PRF filling is not observable with the x-rays (A). Six months after surgery, a control CT-scan was performed and showed that implants were surrounded in a new bone tissue. Only the last 2 mm of the implants were not clearly covered with bone, but a shadow image appeared up to the implant tip (white dotted line), which indicated the presence of a tissue not yet calcified. Moreover, the lateral bone window was no more visible, and the cortical outline seemed already reconstructed (B). On the panoramic x-ray, most of the implant cavity was filled with new bone, but the new sinus floor was still blurred (C). Four years after sinus filling, panoramic x-ray showed that the subsinus cavity filled with PRF was completely filled with bone up to the implant tip, leading to a final bone gain around 12 mm. The new periimplant bone was very natural, and the final sinus floor clearly appeared in the continuation of the implant tip. The final bone regenerated volume looked like exactly adapted to the size of the implants (D).
high position. Moreover, a large bone window reduced the regeneration potential of the subsinus cavity walls and could, thus, impair bone healing. Thus, it was quickly decided to reduce the size of the bony window and to place the window in the upper part of the sinus wall, ϳ6 to 8 mm above the crestal line (Fig. 3) . These simple evolutions of the technique seemed highly beneficial to secure this procedure and to increase the bone regeneration potential of the filled subsinus cavity.
The second main change was related to the use of the bone plate (from the access window) during the surgery. In the last cases of this series, it was decided to carefully separate the bone plate (from the access window) from the lifted sinus membrane and to use it for subsinus cavity closure after filling with the PRF clots. To block this bone plate in the right position, this rectangular fragment could be placed transversely on the bone window, and the final PRF membrane was placed over it. This modified technique seemed relevant to increase the regeneration potential of the filled subsinus cavity. Both the implant systems used in this study show similar profile, with a typical tapered and microthreaded collar. It was the more adequate implant shape and design for this specific application where implants have to be placed in a very limited residual bone height. In this case series, a total of 52 implants were placed. Seven patients were treated with 19 Astra implants (AstraTech; Figs. 1 and 2), and 13 patients with 33 Intra-Lock implants (Ossean; Intra-Lock, Boca Raton, FL; Fig. 3 ). Astra implants were 13 mm long and 4.5 mm in diameter; IntraLock implants were 11.5 or 13 mm long and 4.3 mm in diameter.
RESULTS OF A 6-YEAR EXPERIENCE
Implants were inserted in 23 first molar, 19 second molar, and 10 premolar sites, under clean but not sterile conditions as defined by Scharf and Tarnow. 33 In 3 patients, clear sinus membrane perforations were noticed during the sinus-lift and patched easily with PRF membranes (Fig. 1) . After surgery, healing was uneventful for all patients. Six months after surgery, all implants were clinically stable during abutment tightening.
The maximum follow-up was 6 years, and all patients were followed up for a minimum of 2 years. Clinical follow-up was associated with retroalveolar and panoramic x-rays just after implant placement, after 6 months, after 1 year, and finally after each following year (Figs. 2 and 3) . In some cases, low-dose volumetric computed radiography or CT scan examinations were performed 6 months after sinus-lift surgery, and even sometimes after 1 year or more, to evaluate accurately the sinus bone gain around each implant.
The main results in this case series were that no implant was lost during this 6-year experience and that the vertical bone gain (assessed by x-ray follow-up) Fig. 3 . This patient showed SA4 sinus morphology (A). The sinus lateral bone window was smaller than in previous cases and placed in the upper part of the sinus wall (ϳ6 -8 mm above the crestal line). After careful elevation of the Schneiderian membrane, the window bone plate was still attached to the sinus membrane (B). Intra-Lock implants were inserted, and their tip maintained the Schneiderian membrane in high position (C). The new subsinus cavity was then filled with PRF clots (D), and the bone window was covered with a PRF membrane a sole protection (E). After 3 months, the panoramic x-ray showed a blurred opacity around the implant (F). After 3 years, the x-ray proved an almost complete bone regeneration around the implants, with a clear cortical sinus floor in the continuation of the implant end (G).
was always substantial and stable. 34 All implants were inserted in a residual bone height between 1 and 3 mm (1.8 Ϯ 0.5). Thus, the final bone gain was always very significant with these quite long implants, between 8.5 and 12 mm bone gain (10.4 Ϯ 1.2) . The final level of the new sinus floor was sometimes difficult to assess precisely with only x-rays as investigation tools, but it seemed that the position of the final sinus floor was always in the continuation of the implant end (Figs. 2 and 3) .
The periimplant crestal bone height was always very stable. This result could be associated with the typical microthreaded profiles and the similar platform-switching prosthetic system 35 of both implant systems. It proved that this kind of screw implants placed in residual bone height can maintain a strong periimplant bone tissue as long as they are blocked in stable position.
No statistical comparison between the different implant systems was performed to define which implant system was the more efficient for bone gain around implants. Indeed, in this technique, implants were used as tent pegs to delineate the bone regeneration chamber, and the implant shape or surface did not seem to influence the position of the new sinus floor.
DISCUSSION
PRF Membrane, an Inexpensive and Powerful Tool to Secure Sinus-Lift
Filling or not filling during sinus-lift? During sinus-lift, the biomaterials are used as space maintainers and bone scaffold to promote bone regeneration in the subsinus area. The general consensus is that many biomaterials are usable in the sinus, because of the high osteogenic activity of the Schneiderian membrane. 7 Consequently, both crestal approach with osteotome (Summers technique) 4 and lateral sinus-lift can easily be performed without any material, particularly for small grafting volume. 10, 11, 36 Unfortunately, when no filling is used, some authors have shown that the true bone gain is in fact always limited and that implant apical ends might be enmeshed in the sinus connective tissue and, thus, not osseointegrated.
37,38
Choukroun's PRF is a simple and inexpensive technique that can be used currently in daily practice. This technique is the simplest and cheapest way to produce autologous fibrin membrane or platelet concentrate. 12 The systematic use of this biomaterial during sinus-lift, with or without bone substitute, seems a very interesting option, particularly for the protection of the Schneiderian membrane. Moreover, the use of PRF as sole filling material seems able to stabilize a quite high amount of bone around the implants: indeed, in this case series, the long term follow-up showed that periimplant bone finally stabilized up to the implant end. This result was quite different from some actual available data about the sinus-lift procedure without any material, 38 and it showed that the use of PRF, as an optimized natural blood clot, seemed to avoid the enmeshment of the implant end in a thick sinus connective tissue.
This result could be the consequence of the applications of PRF membranes on the Schneiderian membrane. Indeed, a PRF cover on the sinus membrane can potentially improve the healing of the membrane, induce a stimulation of the periosteum, and perhaps stabilize a new bone volume at the end of the implant. 39, 40 This effect may be both related to the platelet 41 and fibrin 42,43 content of the PRF membrane. From a practical standpoint, the use of PRF membranes on the Schneiderian membrane is a simple mechanical and biological protection that can be used in daily practice, whatever the filling material.
Therefore, we can clearly answer the question: Filling or not filling during sinus-lift? Filling is not absolutely necessary because the natural blood clot inside the subsinus chamber is enough for bone healing; but filling at least with PRF, ie, optimized blood clots, seems the adequate alternative to improve natural healing and to secure the surgical procedure.
Implant Design and Evolution of the Technical Procedure
In this case series, all implants achieved primary stability even in a thin residual bone height. Implant stabilization was achieved by the microthreads of the implant collar and its adequate tapered profile. This implant design seems the best for such subsinus implantation, to block correctly the implant, but other designs could be discussed, such as microthreaded nontapered implants or tapered nonmicrothreaded implants. However, it seems very important to be as cautious as possible with this technique and to use the more adequate profile from the mechanical point of view.
The influence of the implant shapes and surfaces on the bone regeneration in the cavity could also be discussed, because both implants used in this series showed improved surfaces. 44 New surfaces (such as Astra Osseospeed or Intra-Lock Ossean) influence bone cell response, [45] [46] [47] and it could, thus, be a relevant parameter to improve local bone regeneration.
Another key point was revealed in this case series, concerning the effect of the PRF membrane placed on the sinus bone window. It is often considered that the lateral window of the sinus should be protected with a membrane (such as collagen membranes) to avoid invagination of the mucogingival tissues in the subsinus cavity. The general explanation about this phenomenon is that the subsinus cavity must be protected with a barrier such as a guided bone regeneration area. In the first cases of this series, PRF membranes were used as sole protection membrane covering each sinus window. The x-ray analyses of these cases 6 months after surgery showed no invagination/fibrosis, and a neat cortical limit was clearly observed after 3 years, even if the cortical surface appeared to be a little bit depressed at the level of the wide bone window (this was another argument to reduce the size of the window).
This result indicated that PRF membranes alone were able to protect the sinus graft area. This point is very interesting, because PRF is an inexpensive autologous biomaterial with a significant slow release of growth factors and could easily replace xenogeneic and expensive collagen membranes in this application.
48
CONCLUSION
The use of PRF as sole grafting material during simultaneous sinus-lift and implantation is a secure and reliable option. This autologous and inexpensive material can be considered as an optimized blood clot, and this L-PRF matrix seems a relevant biomaterial for natural bone regeneration. However, in this technique, the experience of the surgeon and the choice of the implant profile are also significant parameters, because implant stability in the residual alveolar ridge is the key condition to the firm support of the implants as tent pegs on the Schneiderian membrane. Finally, by extension, the systematic use of PRF during sinus-lift, with or without bone grafting material, may be beneficial, particularly for the protection of the Schneiderian membrane, and should be analyzed in further studies.
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PALABRAS CLAVES:
Implante dental, fibrina, fibrina rica en plaquetas (PRF por sus siglas en inglés), plasma rico en plaquetas (PRP por sus siglas en inglés) Membranas L-PRF foram usadas para cobrir a membrana Schneideriana, as pontas do implante serviram como "paus de barraca" para as membranas da cavidade remendadas com L-PRF, e a subcavidade foi finalmente preenchida com coágulos de L-PRF. O acompanhamento clínico e radiográfico foi realizado logo após a colocação do implante, após 6 meses, 1 ano e cada ano seguinte. Resultados: Seis meses após a cirurgia, todos os implantes estavam clinicamente estáveis durante o aperto do suporte. O acompanhamento máximo foi de 6 anos e todos os pacientes foram acompanhados durante o mínimo de 2 anos. Nenhum implante foi perdido durante esta experiência de 6 anos e o ganho de osso vertical foi sempre substancial, entre 8.5 e 12 mm de ganho de osso (10.4 Ϯ 1.2). O nível final da nova superfície da cavidade esteve sempre em continuação com a ponta apical do implante e a altura da crista óssea do peri-implante ficou estável. Conclusão: O uso de L-PRF como único material de enchimento durante a elevação e implantação simultâneas da cavidade parece ser uma opção cirúrgica confiável, promovendo a regeneração natural do osso. Hemen implant yerleştirme sonrasında, 6 ay sonra, 1 yıl sonra ve sonraki her yılda bir kez klinik ve radyografik izlem yapıldı. Bulgular: Cerrahiden altı ay sonra abutman sıkıştırma esnasında tüm implantların klinik olarak stabil oldugu görüldü. En uzun izlem dönemi 6 yıldı ve hastaların tümü en az 2 yıl boyunca takip edildi. 6 yıl boyunca implant kaybı olmadı ve dikey kemik kazancı daima kayda deger olup, 8.5 ile 12 mm arasında degişti (10.4 Ϯ 1.2). Yeni sinüs tabanının son düzeyi daima implantın apikal ucuna kadar devam etti ve peri-implant sırt kemik yüksekligi stabil idi. Sonuç: Eş zamanlı sinüs kaldırma ve implantasyon işlemi sırasında L-PRF'nin tek dolgu materyali olarak kullanılması dogal kemik rejenerasyonunu teşvik eden güvenilir bir cerrahi seçenektir.
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